As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.
What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?
Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.
A recent study led by professor Jonathan Silverberg involving over 30,000 participants has highlighted the significant psychosocial burden faced by adults with early-onset atopic dermatitis (AD). Learn more and continue reading.
Olet poistumassa Sivustolta campus.sanofi/fi. Sanofi ei ole vastuussa tämän ulkoisen verkkoSivuston sisällöstä.
Tämä sivusto on suunnattu terveydenhuollon ammattilaisille. Vahvista valinta päästäksesi näkemään sisältöjä kuten videoita, podcasteja ja muita materiaaleja.